Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Melatonin affects gene expression in goat hair follicles, potentially increasing cashmere production.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Excessive sun protection might cause frontal fibrosing alopecia by disrupting skin immune balance.

Defective repair processes may cause immune activation and inflammation in psoriatic disease.

Hair dye ingredient PPD causes cell death and aging in human hair cells by altering microRNA levels.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Targeting autophagy can help treat skin disorders like vitiligo and atopic dermatitis.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Improving human hair follicle models is crucial for better hair loss treatments.

Shaoyao Gancao decoction may treat alopecia areata by affecting the PI3K/AKT signaling pathway.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

The Chinese herbal supplement BeauTop can potentially boost hair growth and thickness by increasing a protein called Vascular Endothelial Growth Factor.

The document concludes that various signaling pathways and genetic factors are crucial for chicken feather development, affecting poultry quality.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.